HIV Prevention Trials Network (HPTN)
Rita Lisa Labbett, MPH, CCRC, currently serves as a Clinical Research Manager at the HIV Prevention Trials Network (HPTN) since October 2021, focusing on qualitative interviewing and behavioral data analysis for HIV prevention clinical trials. Prior to this role, Labbett worked as a Clinical Research Coordinator at Preferred Primary Care Physicians from July 2016 to October 2021 and as a Research and Behavioral Coordinator at the Microbicides Trials Network from September 2010 to November 2014. Labbett began a career in research at Children's Hospital of Pittsburgh as a Research Coordinator for the SAFE Study between 2003 and 2008. Educationally, Labbett holds a Master of Public Health from Walden University (2008-2010) and a Bachelor of Arts in Journalism/Communications from Point Park University (1989-1994), and is currently pursuing a Ph.D. in Family Studies and Interventions from Walden University.
This person is not in any teams
This person is not in any offices
HIV Prevention Trials Network (HPTN)
HPTN studies evaluate innovative strategies in populations and geographical regions that bear a disproportionate burden of risk including cisgender women, adolescents and young people, cisgender men who have sex with men (MSM), transgender people, and people who use substances at sites located in Asia, Europe, sub-Saharan Africa, and North and South America. Since its inception in 1999, the HPTN has had a long history of successfully conceptualizing, designing, and implementing, complex clinical research studies with a focus on biomedical interventions and integrated strategies to prevent HIV acquisition and transmission with more than 65 clinical research sites (CRSs) globally. The HPTN has long-standing partnerships with pharmaceutical companies, academic researchers worldwide, the Bill and Melinda Gates Foundation and several other organizations. In addition, the HPTN has forged collaborations to develop integrated strategies with PEPFAR, the Centers for Disease Control and Prevention (CDC) and both ministries and departments of health in several countries. HPTN receives its funding from three U.S. National Institutes of Health (NIH): the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, and the National Institute on Drug Abuse.